1Yadav, H, Jain, S & Sinha, PR (2008) The effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei on gastropathic consequences in diabetic rats. J Med Food 11, 62–68.
2Yadav, H, Jain, S & Sinha, PR (2007) Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 23, 62–68.
3Yadav, H, Jain, S & Sinha, PR (2008) Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats. J Dairy Res 75, 189–195.
4Guarner, F & Schaafsma, GJ (1998) Probiotics. Int J Food Microbiol 39, 237–238.
5Food and Agriculture Organization & World Health Organization (2001) Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. . Geneva: WHO.
6Marco, ML, Pavan, S & Kleerebezem, M (2006) Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol 17, 204–210.
7Jacobsen, CN, Rosenfeldt Nielsen, V, Hayford, AE, et al. (1999) Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 65, 4949–4956.
8Cani, PD & Delzenne, NM (2009) The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 15, 1546–1558.
9Turnbaugh, PJ, Ley, RE, Mahowald, MA, et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031.
10Jia, W, Li, H, Zhao, L, et al. (2008) Gut microbiota: a potential new territory for drug targeting. Nat Rev Drug Discov 7, 123–129.
11Walker, WA (2008) Mechanisms of action of probiotics. Clin Infect Dis 46, Suppl. 2, S87–S91.
12Rescigno, M, Urbano, M, Valzasina, B, et al. (2001) Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2, 361–367.
13Guarner, F & Malagelada, JR (2003) Gut flora in health and disease. Lancet 361, 512–519.
14Madsen, K, Cornish, A, Soper, P, et al. (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121, 580–591.
15Cani, PD, Neyrinck, AM, Fava, F, et al. (2007) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50, 2374–2383.
16Guha, M & Mackman, N (2001) LPS induction of gene expression in human monocytes. Cell Signal 13, 85–94.
17Pickup, JC, Mattock, MB, Chusney, GD, et al. (1997) NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40, 1286–1292.
18Pickup, JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27, 813–823.
19Shoelson, SE, Lee, J & Goldfine, AB (2006) Inflammation and insulin resistance. J Clin Invest 116, 1793–1801.
20Konstantinov, SR, Smidt, H, de Vos, VM, et al. (2008) S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci U S A 105, 19474–19479.
21Chen, CC, Chiu, CH, Lin, TY, et al. (2008) Effect of probiotics L. acidophilus on C. rodentium colitis: the role of dendritic cells. Pediatr Res .
22Ouwehand, AC, Tiihonen, K, Saarinen, M, et al. (2009) Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. Br J Nutr 101, 367–375.
23Sanders, ME & Klaenhammer, TR (2001) Invited review: the scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic. J Dairy Sci 84, 319–331.
24Altermann, E, Russell, WM, Azcarate-Peril, MA, et al. (2005) Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM. Proc Natl Acad Sci U S A 102, 3906–3912.
25DeFronzo, RA, Tobin, JD & Andres, R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237, E214–E223.
26Andreasen, AS, Krabbe, KS, Krogh-Madsen, R, et al. (2008) Human endotoxemia as a model of systemic inflammation. Curr Med Chem 15, 1697–1705.
27World Health Organization (2006) Definitions and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. . Geneva: WHO.
28Walter, J, Hertel, C, Tannock, GW, et al. (2001) Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl Environ Microbiol 67, 2578–2585.
29Muyzer, G, de Waal, EC & Uitterlinden, AG (1993) Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol 59, 695–700.
30ben Omar, N & Ampe, F (2000) Microbial community dynamics during production of the Mexican fermented maize dough pozol. Appl Environ Microbiol 66, 3664–3673.
31Ferrannini, E & Mari, A (1998) How to measure insulin sensitivity. J Hypertens 16, 895–906.
32Brehm, A & Roden, M (2009) Glucose clamp techniques. In Clinical Diabetes Research, Methods and Techniques, pp. 43–67 [Roden, M, editor]. Chichester: John Wiley and Sons Ltd.
33Taudorf, S, Krabbe, KS, Berg, RM, et al. (2007) Human models of low-grade inflammation: bolus versus continuous infusion of endotoxin. Clin Vaccine Immunol 14, 250–255.
34Andreasen, AS, Pedersen-Skovsgaard, T, Mortensen, OH, et al. (2009) The effect of glutamine infusion on the inflammatory response and HSP70 during human experimental endotoxaemia. Crit Care 13, R7.
35Andreasen, AS, Pedersen-Skovsgaard, T, Berg, RMG, et al. (2009) Type 2 diabetes is associated with impaired cytokine response and adhesion molecule expression in human endotoxaemia. Intensive Care Med .
36Membrez, M, Blancher, F, Jaquet, M, et al. (2008) Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J 22, 2416–2426.
37Brugman, S, Klatter, FA, Visser, JT, et al. (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49, 2105–2108.
38Ma, X, Hua, J & Li, Z (2008) Probiotics improve high-fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol 49, 821–830.
39Diaz-Ropero, MP, Martin, R, Sierra, S, et al. (2007) Two Lactobacillus strains, isolated from breast milk, differently modulate the immune response. J Appl Microbiol 102, 337–343.
40Hotamisligil, GS, Arner, P, Caro, JF, et al. (1995) Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95, 2409–2415.
41Fink, LN, Zeuthen, LH, Ferlazzo, G, et al. (2007) Human antigen-presenting cells respond differently to gut-derived probiotic bacteria but mediate similar strain-dependent NK and T cell activation. FEMS Immunol Med Microbiol 51, 535–546.
42Sato, M, Uzu, K, Yoshida, T, et al. (2008) Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. Br J Nutr 99, 1013–1017.
43Backhed, F, Manchester, JK, Semenkovich, CF, et al. (2007) Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 104, 979–984.
44Backhed, F, Ding, H, Wang, T, et al. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101, 15718–15723.
45Hotamisligil, GS (2006) Inflammation and metabolic disorders. Nature 444, 860–867.